Diagnosis of Alzheimer-type dementia: a preliminary comparison of positron emission tomography and proton magnetic resonance

Journal Article · Thu Nov 15 23:00:00 EST 1984 · JAMA, J. Am. Med. Assoc.; (United States)

DOI:https://doi.org/10.1001/jama.252.19.2750· OSTI ID:6333883

Friedland, R P; Budinger, T F; Brant-Zawadzki, M; Jagust, W J

The use of positron emission tomography with (18F)-2-fluoro-2-deoxy-D-glucose (FDG) to study glucose metabolism in dementia is described and compared with the use of magnetic resonance imaging. These studies suggest that physiological imaging with PET may be superior to MR as it is currently used in the diagnosis of dementia-like diseases. Pet is currently limited to a few centers; however, single photon emission CT can provide regional physiological data without the need for a local cyclotron. 15 references, 2 tables.

• Research Organization: Veterans Administration Medical Center, Martinez, CA
• DOE Contract Number: AC03-76SF00098
• OSTI ID: 6333883
• Journal Information: JAMA, J. Am. Med. Assoc.; (United States), Journal Name: JAMA, J. Am. Med. Assoc.; (United States) Vol. 252:19; ISSN JAMAA
• Country of Publication: United States
• Language: English

Related Subjects

550600 -- Medicine
550601* -- Medicine-- Unsealed Radionuclides in Diagnostics
62 RADIOLOGY AND NUCLEAR MEDICINE
ALDEHYDES
BETA DECAY RADIOISOTOPES
BETA-PLUS DECAY RADIOISOTOPES
CARBOHYDRATES
COMPARATIVE EVALUATIONS
COMPUTERIZED TOMOGRAPHY
DIAGNOSIS
DIAGNOSTIC TECHNIQUES
DIAGNOSTIC USES
DISEASES
DRUGS
EMISSION COMPUTED TOMOGRAPHY
FLUORINE 18
FLUORINE ISOTOPES
GLUCOSE
HEXOSES
HOURS LIVING RADIOISOTOPES
IMAGES
ISOTOPES
LABELLED COMPOUNDS
LIGHT NUCLEI
METABOLISM
MONOSACCHARIDES
NERVOUS SYSTEM DISEASES
NUCLEI
ODD-ODD NUCLEI
ORGANIC COMPOUNDS
PATIENTS
POSITRON COMPUTED TOMOGRAPHY
RADIOISOTOPES
RADIOPHARMACEUTICALS
SACCHARIDES
SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY
TOMOGRAPHY
USES